ProKidney Corp. (PROK) Current Ratio
- Current ratio · latest quarter: Value 8.36×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 8.36× | Current assets / current liabilities. $189.77M ÷ $22.71M ≈ 8.36× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 189.77M USD | Assets, Current |
| Current obligations | 22.71M USD | Liabilities, Current |
| Cash and equivalents | 74.87M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 1.61M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $189.77M | $22.71M | $74.87M | (m) | (m) | (m) | $1.61M | (m) | 8.36× |
| 2026-03-31 | $234.90M | $25.93M | $101.89M | (m) | (m) | (m) | $2.59M | (m) | 9.06× |
| 2025-12-31 | $280.68M | $30.74M | $108.54M | (m) | (m) | (m) | $940.00K | (m) | 9.13× |
| 2025-09-30 | $299.99M | $29.06M | $95.32M | (m) | (m) | (m) | $1.94M | (m) | 10.32× |
| 2025-06-30 | $324.44M | $28.26M | $84.94M | (m) | (m) | (m) | $2.44M | (m) | 11.48× |
| 2025-03-31 | $359.66M | $32.81M | $97.81M | (m) | (m) | (m) | $3.12M | (m) | 10.96× |
| 2024-12-31 | $395.88M | $36.22M | $99.12M | (m) | (m) | (m) | $3.63M | (m) | 10.93× |
| 2024-09-30 | $430.23M | $25.18M | $108.09M | (m) | (m) | (m) | $2.85M | (m) | 17.09× |
| 2024-06-30 | $450.26M | $20.59M | $214.51M | (m) | (m) | (m) | $2.93M | (m) | 21.87× |
| 2024-03-31 | $340.16M | $19.30M | $84.39M | (m) | (m) | (m) | $3.38M | (m) | 17.62× |
| 2023-12-31 | $374.15M | $25.04M | $60.65M | (m) | (m) | (m) | $5.10M | (m) | 14.94× |
| 2023-09-30 | $406.42M | $20.99M | $191.39M | (m) | (m) | (m) | $4.48M | (m) | 19.37× |
| 2023-06-30 | $466.43M | $24.50M | $243.55M | (m) | (m) | (m) | $2.83M | (m) | 19.04× |
| 2023-03-31 | $480.14M | $11.28M | $271.63M | (m) | (m) | (m) | $3.80M | (m) | 42.57× |
| 2022-12-31 | $504.72M | $10.87M | $490.25M | (m) | (m) | (m) | $3.04M | (m) | 46.42× |
| 2022-09-30 | $519.37M | $9.84M | $506.33M | (m) | (m) | (m) | $3.45M | (m) | 52.78× |
| 2022-06-30 | $632.30K | $7.93M | (m) | (m) | (m) | (m) | (m) | (m) | 0.08× |
| 2022-03-31 | $594.98K | $5.41M | (m) | (m) | (m) | (m) | (m) | (m) | 0.11× |
| 2021-12-31 | $27.27M | $12.31M | $20.56M | (m) | (m) | (m) | $2.83M | (m) | 2.21× |
| 2021-09-30 | $1.44M | $55.14K | $542.30K | (m) | (m) | (m) | (m) | (m) | 26.11× |
| 2021-06-30 | $243.14K | $603.13K | $223.54K | (m) | (m) | (m) | (m) | (m) | 0.40× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.